GW stock popped late Monday after the biotech's first-quarter sales beat estimates. GW also said cannabis medicine Epidiolex succeeded in a test of patients with tuberous sclerosis complex. Read More...
Biotech Stock Pops After Cannabis Medicine Outsells Expectations
GW stock popped late Monday after the biotech’s first-quarter sales beat estimates. GW also said cannabis medicine Epidiolex succeeded in a test of patients with tuberous sclerosis complex.
Add Comment